The 7th Wuwei Gynecologic Oncology Academic Conference 2026 Successfully Held

The 7th Wuwei Gynecologic Oncology Academic Conference 2026 Successfully Held

To establish a high‑level academic cooperation platform for standardized diagnosis and treatment of gynecologic tumors, exchange of cutting‑edge research findings, and integrated Chinese‑Western medicine approaches — addressing clinical challenges, unifying practice standards, enhancing regional gynecologic oncology care and research capabilities, and better serving female cancer patients with high‑quality, precise, and whole‑course care — the Department of Gynecologic Oncology at our hospital carefully organized the Training Course on Gynecologic Malignancy Diagnosis and Treatment Capacity Improvement and Academic Conference.

On September 19, the "7th Wuwei Gynecologic Oncology Academic Conference 2026," hosted by the Wuwei Medical Association and organized by Wuwei Cancer Hospital, was grandly convened in the main building of Gansu Wuwei Heavy Ion Hospital. The conference featured special academic presentations by renowned experts from institutions including the Air Force Medical University Xijing Hospital, the First Affiliated Hospital of Xi'an Jiaotong University, Gansu Provincial Maternity and Child Health Care Hospital, and the Gansu Academy of Traditional Chinese Medicine. In‑depth discussions centered on key topics and industry hotspots including surgical technique innovation, clinical diagnostic reasoning, and whole‑course patient management — laying a solid academic foundation for the standardized and precise development of regional gynecologic oncology care.

Zhang Yanshan, Vice President of Gansu Wuwei Cancer Hospital, delivered the opening address

An Cunlian, Director of the Department of Gynecologic Oncology at Gansu Wuwei Cancer Hospital, delivered the welcome address and presented on Whole‑Course Standardized Management of Ovarian Cancer

Li Jing, Deputy Director of the Department of Gynecologic Oncology at Gansu Wuwei Cancer Hospital, chaired the session

Liu Shujuan, Director of the Department of Obstetrics and Gynecology at Xijing Hospital and Doctoral Supervisor, presented Diagnostic and Therapeutic Approaches to Uterine Adenocarcinoma

Professor Mi Denghai, former President of Gansu Wuwei Cancer Hospital, presented Heavy Ion + Traditional Chinese Medicine in Anticancer Treatment

Professor Dang Yun from Gansu Provincial Maternity and Child Health Care Hospital presented The Dos and Don'ts in the Diagnosis and Treatment of Endometrial Cancer

Professor Li Qiling from the First Affiliated Hospital of Xi'an Jiaotong University presented Cardiophrenic Lymph Node Resection in Ovarian Cancer

Academic Leadership, Protecting Women's Health. With the in‑depth discussion of all topics, the 7th Wuwei Gynecologic Oncology Academic Conference 2026 successfully concluded. This academic feast of intellectual exchange not only rooted cutting‑edge concepts in Wuwei but also reinforced our hospital's commitment to a patient‑centered philosophy. Gansu Wuwei Cancer Hospital will integrate the new concepts and technologies from this conference into clinical practice, joining hands with experts from within and beyond the province to provide more compassionate, higher‑quality care for every gynecologic cancer patient. We remain ever dedicated to safeguarding women's health.

Department of Gynecologic Oncology Profile

The Department of Gynecologic Oncology at Gansu Wuwei Cancer Hospital is a municipal‑level key discipline. Director An Cunlian currently serves as Chair of the Gynecologic Oncology Professional Committee of the Wuwei Medical Association. The department has 1 Chief Physician, 2 Associate Chief Physicians, 2 Attending Physicians, and 2 Resident Physicians, including 1 with a master's degree. The department has long been dedicated to the diagnosis, treatment, and research of gynecologic tumors. In routine surgery, the department is proficient in LEEP cervical conization, laparoscopic/abdominal total hysterectomy and adnexectomy, uterine and vaginal wall prolapse repair, laparoscopic/abdominal benign uterine and ovarian tumor resection, complex pelvic tumor resection, hysteroscopy, and hysteroscopic resection of uterine lesions.

Notably, in the treatment of gynecologic malignancies, the department holds significant regional advantages. It is proficient in laparoscopic/abdominal pelvic lymph node dissection, laparoscopic radical hysterectomy for early cervical cancer, comprehensive staging surgery for cervical cancer, comprehensive staging surgery for early ovarian cancer, maximal cytoreductive surgery for advanced ovarian cancer, laparoscopic and abdominal comprehensive staging surgery for endometrial cancer, and radical vulvectomy. The department has also pioneered the application of robot‑assisted surgical techniques. As this technology has matured, robot‑assisted comprehensive staging surgery for endometrial cancer has gradually become the preferred option for patients, significantly enhancing surgical precision and minimally invasive outcomes.

In addition, the department provides a range of adjunctive treatments including radiotherapy, chemotherapy, intraperitoneal perfusion chemotherapy, biological immunotherapy, and targeted therapy — forming a personalized, multidisciplinary comprehensive care system. With advanced techniques, state‑of‑the‑art equipment, and high‑quality services, the department is committed to improving survival rates and quality of life for gynecologic cancer patients and serves as a key force in the diagnosis and treatment of gynecologic malignancies in the region.

Writer: Mao Peng

First Review: Zhang Jie

Second Review: Guo Yishan

Third Review: Cai Qinghua